Suscribirse

Les marqueurs sériques sont-ils corrélés au caractère invasif de la procédure en arthroplastie primaire de hanche ? Étude prospective randomisée comparant les approches antérieures et latérales directes - 17/06/21

Do serum markers correlate with invasiveness of the procedure in THA? A prospective randomized study comparing direct anterior and lateral approaches

Doi : 10.1016/j.rcot.2021.04.014 
Raffaele Iorio, Edoardo Viglietta , Daniele Mazza, Ferdinando Iannotti, Ilaria Nicolosi, Alessandro Carrozzo, Attilio Speranza, Andrea Ferretti
 University of Rome “Sapienza”, Sant’Andrea Hospital, Via di Grottarossa, 1035, 00189 Rome, Italy 

Auteur correspondant. University of Rome La Sapienza, Sant’Andrea Hospital, via di grottarossa, 1035/1039, Rome 00189, ItalyUniversity of Rome La Sapienza, Sant’Andrea Hospitalvia di grottarossa, 1035/1039Rome 00189Italy
En prensa. Pruebas corregidas por el autor. Disponible en línea desde el Thursday 17 June 2021
This article has been published in an issue click here to access

Abstract

Background

Advantages of minimally invasive approaches for total hip arthroplasty are still matter of debate. Serum markers have been assessed as objective method to quantify muscle damage after surgery but in literature ambiguous results have been reported. The aim of this prospective randomized study was to: 1) compare serum markers elevation between a minimally invasive direct anterior approach (DAA) and a direct lateral approach (DLA), 2) to establish a correlation between serum markers increase and other peri-operative variables.

Hypothesis A lesser elevation of markers could be found in patients who underwent a minimally invasive DAA.

Patients and methods

Seventy patients were enrolled and randomly divided in two groups according to the type of the approach. All patients were treated with the same implant by the same surgeon and received the same rehabilitation protocol. Demographic data, pre-operative Harris Hip Score (HHS) and operative time were recorded. Myoglobin, creatine kinase MB (CK-MB), troponin I, C-reactive protein (CRP), haemoglobin (HB) and pain levels were measured pre- and post-operatively.

Results

Mean post-operative rise were 524.9±134.6 and 667.8±409.5 for myoglobin, 4.8±2.5 and 6.6±3.7 for CK-MB, and 16.9±5.3 and 15.4±6.4 for PCR, in DAA and DLA groups respectively. In both groups, post-operatively values were significantly higher than pre-operatively (p<0.05). Comparing the two groups, no significant differences in serum markers elevations were found. A significantly lower post-operative pain was found in DAA group than in DLA group [2,9 vs. 4,2 and 2,7 vs. 3,6 in second and third day, respectively (p<0.05)]. No significant correlation was present between the serum marker elevations and age, BMI, HHS, operative time, HB or pain levels (p>0.05).

Conclusion

Serum markers of muscle damage and inflammation increased in the post-operative period without significant differences between DAA and DLA, even though overall trend was higher in DLA group. The DAA group had significantly lower levels of post-operative pain. No significant correlation between pain and serum markers levels was found.

Level of evidence

I; randomized study.

El texto completo de este artículo está disponible en PDF.

Keywords : THA, Approach, Minimally invasive, Direct anterior, Muscle damage



 Cet article peut être consulté in extenso dans la version anglaise de la revue Orthopaedics & Traumatology : Surgery & Research sur Science Direct (sciencedirect.com) en utilisant le DOI ci-dessus.


© 2021  Elsevier Masson SAS. Reservados todos los derechos.
Añadir a mi biblioteca Eliminar de mi biblioteca Imprimir
Exportación

    Exportación citas

  • Fichero

  • Contenido

Bienvenido a EM-consulte, la referencia de los profesionales de la salud.
El acceso al texto completo de este artículo requiere una suscripción.

¿Ya suscrito a @@106933@@ revista ?

Mi cuenta


Declaración CNIL

EM-CONSULTE.COM se declara a la CNIL, la declaración N º 1286925.

En virtud de la Ley N º 78-17 del 6 de enero de 1978, relativa a las computadoras, archivos y libertades, usted tiene el derecho de oposición (art.26 de la ley), el acceso (art.34 a 38 Ley), y correcta (artículo 36 de la ley) los datos que le conciernen. Por lo tanto, usted puede pedir que se corrija, complementado, clarificado, actualizado o suprimido información sobre usted que son inexactos, incompletos, engañosos, obsoletos o cuya recogida o de conservación o uso está prohibido.
La información personal sobre los visitantes de nuestro sitio, incluyendo su identidad, son confidenciales.
El jefe del sitio en el honor se compromete a respetar la confidencialidad de los requisitos legales aplicables en Francia y no de revelar dicha información a terceros.


Todo el contenido en este sitio: Copyright © 2024 Elsevier, sus licenciantes y colaboradores. Se reservan todos los derechos, incluidos los de minería de texto y datos, entrenamiento de IA y tecnologías similares. Para todo el contenido de acceso abierto, se aplican los términos de licencia de Creative Commons.